We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
(+8.9%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
8.49%
Top 10 Holdings %
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$127M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$126M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$122M |
| 4 |
SkinHealth Systems
SKIN
|
+$90.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$210M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$187M |
| 3 |
XYZ
Block Inc
XYZ
|
+$111M |
| 4 |
Danaher
DHR
|
+$109M |
| 5 |
Monster Beverage
MNST
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Financials | 16.56% |
| 3 | Technology | 13.74% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Communication Services | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Paylocity
PCTY
$6.71B
| $19.1M | 0.08% |
67,956
+12,000
| +21% | +$2.88M |
|
277
Stellantis
STLA
$16.5B
| $19M | 0.08% |
991,549
-695,563
| -41% | -$13.8M |
|
278
Fox Class A
FOXA
$23.2B
| $19M | 0.08% |
472,831
-1,180,893
| -71% | -$43.5M |
|
|
SPAQ
279
DELISTED
Spartan Acquisition Corp. III
SPAQ
| $18.9M | 0.08% |
1,912,222
+690,128
| +56% | +$6.78M |
|
280
Medtronic
MDT
$107B
| $18.9M | 0.08% |
150,706
+71,818
| +91% | +$9.3M |
|
281
Spotify
SPOT
$99.2B
| $18.9M | 0.08% |
83,828
-16,954
| -17% | -$4M |
|
|
AVAN
282
DELISTED
Avanti Acquisition Corp.
AVAN
| $18.9M | 0.08% |
1,927,331
+825,947
| +75% | +$8.05M |
|
283
Steven Madden
SHOO
$3.12B
| $18.9M | 0.08% |
469,476
+97,548
| +26% | +$4.03M |
|
|
SPLK
284
DELISTED
Splunk Inc
SPLK
| $18.8M | 0.08% |
130,124
+68,849
| +112% | +$10M |
|
|
SVFA
285
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
| $18.8M | 0.08% |
1,921,638
+1,766,923
| +1,142% | +$17.3M |
|
286
Coca-Cola Europacific Partners
CCEP
$46.5B
| $18.7M | 0.08% |
339,047
+40,189
| +13% | +$2.39M |
|
287
CALL
General Motors
GM
$74.7B
| $18.7M | 0.08% |
+354,600
| New | +$18.8M |
|
|
LGAC
288
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $18.6M | 0.08% |
1,908,017
+508,867
| +36% | +$4.95M |
|
289
Celsius Holdings
CELH
$6.93B
| $18.3M | 0.08% |
609,495
-1,106,094
| -64% | -$28.4M |
|
290
Etsy
ETSY
$7.65B
| $18.2M | 0.08% |
87,747
-430,151
| -83% | -$87.2M |
|
291
CALL
Thermo Fisher Scientific
TMO
$211B
| $18.2M | 0.08% |
+31,900
| New | +$17.5M |
|
292
NetEase
NTES
$76.5B
| $18.1M | 0.08% |
212,130
+198,273
| +1,431% | +$18.7M |
|
|
PV
293
DELISTED
Primavera Capital Acquisition Corporation
PV
| $18M | 0.07% |
1,848,023
+1,667,490
| +924% | +$16.2M |
|
294
Live Nation Entertainment
LYV
$41.2B
| $18M | 0.07% |
197,308
+66,669
| +51% | +$5.61M |
|
295
PUT
Johnson & Johnson
JNJ
$635B
| $17.9M | 0.07% |
+110,700
| New | +$18.9M |
|
|
RBCP
296
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $17.8M | 0.07% |
+160,000
| New | +$18.5M |
|
|
NAAC
297
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
| $17.8M | 0.07% |
1,821,129
+924,261
| +103% | +$8.98M |
|
|
MNDT
298
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $17.7M | 0.07% |
995,140
-48,653
| -5% | -$923K |
|
|
NGCA
299
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
| $17.7M | 0.07% |
1,786,518
+286,543
| +19% | +$2.84M |
|
|
LHC
300
DELISTED
Leo Holdings Corp. II
LHC
| $17.7M | 0.07% |
1,813,861
+313,897
| +21% | +$3.04M |
|
Similar funds
Marshall Wace's Q3 2021 Portfolio in Review
As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.
- Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
- Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
- Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
- Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
- Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
- Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
- Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.
Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.